Patents by Inventor Michael G. Zwick

Michael G. Zwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Saliva-based protein profiling
    Publication number: 20040033613
    Abstract: The invention provides methods for profiling proteins present in saliva, and determination of differentials in protein profiles for analysis of gene function, differential gene expression, protein discovery, cellular and clinical diagnostics and drug screening.
    Type: Application
    Filed: May 30, 2003
    Publication date: February 19, 2004
    Inventors: Michael G. Zwick, Charles F. Streckfus, Lanora G. Bigler
  • Compositions and method for modulation of gene expression in plants
    Publication number: 20030014775
    Abstract: An enzymatic nucleic acid molecule with RNA cleaving activity, wherein said nucleic acid molecule modulates the expression of an gene in a plant. A transgenic plant comprising nucleic acids encoding for an enzymatic nucleic acid molecule with RNA cleaving activity, wherein said nucleic acid molecule modulates the expression of a gene in said plant.
    Type: Application
    Filed: September 21, 2001
    Publication date: January 16, 2003
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Michael G. Zwick, Brent V. Edington, James A. McSwiggen, Patricia Ann Owens Merlo, Lining Guo, Thomas A. Skokut, Scott A. Young, Otto Folkerts, Donald J. Merlo
  • Nucleic acid encoding delta-9 desaturase
    Patent number: 6350934
    Abstract: The present invention relates to nucleic acid molecules encoding delta 9 desaturase gene, and expression vectors, plant cells, and transgenic plants expressing delta 9 desaturase nucleic acid. The nucleic acid molecules of the present invention can be used, for example, to decrease delta 9 desaturase activity in plant cells, resulting in decreased unsaturated fatty acid production.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: February 26, 2002
    Assignees: Ribozyme Pharmaceuticals, Inc., DowElanco
    Inventors: Michael G. Zwick, Brent E. Edington, James A. McSwiggen, Patricia Ann Owens Merlo, Lining Guo, Thomas A. Skokut, Scott A. Young, Otto Folkerts, Donald J. Merlo